Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412. (Q45042550)
scientific article published on 2 September 2004
Language:
(P31) (Q13442814)
(P50) (Q87319577)
(P304) 54-60
(P407) (Q1860)
(P433) 1
(P478) 105
(P577) Thursday, September 2, 2004
(P921) (Q181600)
(Q29496)
(Q264118)
(P1433) (Q885070)
(P1476) "Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412." (language: en)
(P2093) Richard M Stone
Daniel J DeAngelo
Virginia Klimek
Ilene Galinsky
Eli Estey
Stephen D Nimer
Wilson Grandin
David Lebwohl
Yanfeng Wang
Pamela Cohen
Edward A Fox
Jennifer Clark
D Gary Gilliland
James D Griffin
(P2860) (Q44497906)
other details
description scientific article published on 2 September 2004

External Links